A standardized composite clinical score for inhaled corticosteroids taper studies in asthmaSHINGO, Sumiko; JI ZHANG; NOONAN, Nancy et al.Drug information journal. 2002, Vol 36, Num 3, pp 501-508, issn 0092-8615, 8 p.Article

Associating genes to drug responseKATZ, David A.Drug information journal. 2002, Vol 36, Num 4, pp 751-761, issn 0092-8615, 11 p.Article

Dose spacing in early dose response clinical trial designsHAMLETT, Anthony; TING, Naitee; CHOUDARY HANUMARA, R et al.Drug information journal. 2002, Vol 36, Num 4, pp 855-864, issn 0092-8615, 10 p.Article

Managing medical information effectively facilitates the quality and time to delivering the final productCOWLRICK, Ivor; DUMON, Jeroen; BAULESER, Manfred et al.Drug information journal. 2002, Vol 36, Num 4, pp 825-829, issn 0092-8615, 5 p.Article

On the use of the accelerated failure time model as an alternative to the proportional hazards model in the treatment of time to event data: A case study in influenzaKAY, Richard; KINNERSLEY, Nelson.Drug information journal. 2002, Vol 36, Num 3, pp 571-579, issn 0092-8615, 9 p.Article

Pharmacogenetic research: Perceptions of informed consentMCPHERSON, Elizabeth C; RAY, Susan C; RIESER, Patricia A et al.Drug information journal. 2002, Vol 36, Num 1, pp 83-93, issn 0092-8615, 11 p.Article

Pharmacy students' attitudes regarding a Web-based guide to drug informationSCHRIMSHER, Robert H; WRIGHT, Stephanie Gooch.Drug information journal. 2002, Vol 36, Num 1, pp 193-200, issn 0092-8615, 8 p.Article

Problems and prospects for good manufacturing practice for herbal drugs in indian systems of medicineMUKHERJEE, Pulok K.Drug information journal. 2002, Vol 36, Num 3, pp 635-644, issn 0092-8615, 10 p.Article

Recommendations to the food and drug administration: Metered dose inhaler tests and methods in the chemistry, manufacturing, and controls draft guidances for metered dose inhalers and dry powder inhalersDrug information journal. 2002, Vol 36, Num 3, pp 549-556, issn 0092-8615, 8 p.Article

Statistical techniques to detect fraud and other data irregularities in clinical questionnaire dataTAYLOR, Rosemary N; MCENTEGART, Damian J; STILLMAN, Eleanor C et al.Drug information journal. 2002, Vol 36, Num 1, pp 115-125, issn 0092-8615, 11 p.Article

Strategies for processing drug information documents and developing drug information filesCURRAN, Charles F; SUNDAR, Murali N.Drug information journal. 2002, Vol 36, Num 3, pp 673-682, issn 0092-8615, 10 p.Article

Streamlining the research and development pipeline by coupling of information technology and biologyMEYER, Hans F.Drug information journal. 2002, Vol 36, Num 1, pp 169-178, issn 0092-8615, 10 p.Article

The attitude of pharmaceutical industry research scientists to browsing and publishing on internet preprint and e-print serversMIRANDA, Giovanna F; GINESTET, Jeanette.Drug information journal. 2002, Vol 36, Num 4, pp 831-837, issn 0092-8615, 7 p.Article

The regulation of dietary supplements in the Republic of ArmeniaGABRIELYAN, Emil; AMROYAN, Elmira; PANOSYAN, Alexander et al.Drug information journal. 2002, Vol 36, Num 4, pp 889-897, issn 0092-8615, 9 p.Article

The single controlled trial: Industry survey indicates that implementation is still a work in progressMILNE, Christopher-Paul.Drug information journal. 2002, Vol 36, Num 2, pp 291-302, issn 0092-8615, 12 p.Article

The value of backup compounds to drug development programsSTOCK, David A; MOLINOFF, Perry B.Drug information journal. 2002, Vol 36, Num 1, pp 95-113, issn 0092-8615, 19 p.Article

Evaluation of the characteristics of safety withdrawal of prescription drugs from worldwide pharmaceutical markets-1960 to 1999MAN FUNG; THORNTON, Anna; MYBECK, Kathy et al.Drug information journal. 2001, Vol 35, Num 1, pp 293-317, issn 0092-8615Article

From local information technology support to a global information management organization in pharmaceutical research and developmentWILHELM, Martin.Drug information journal. 2001, Vol 35, Num 1, pp 17-26, issn 0092-8615Article

Guidelines for economic evaluations in Italy: Recommendations from the Italian Group of Pharmacoeconomic StudiesCAPRI, Stefano; CECI, Adriana; TERRANOVA, Lorenzo et al.Drug information journal. 2001, Vol 35, Num 1, pp 189-201, issn 0092-8615Article

International conference on harmonization-keeping international drug development in harmony?MCCARTHY, Craig.Drug information journal. 2001, Vol 35, Num 2, pp 369-376, issn 0092-8615Article

Is that adverse experience really expected? Guidelines for interpreting and formatting adverse experience information in the United StatesBROWN, Kristina; SYKES, R. Scott; PHILLIPS, George et al.Drug information journal. 2001, Vol 35, Num 1, pp 269-284, issn 0092-8615Article

Preclinical considerations for regulatory submissionsBALDRICK, Paul.Drug information journal. 2001, Vol 35, Num 1, pp 99-105, issn 0092-8615Article

Sources of drug information available to consumersCURRAN, Charles F; OH, Kathleen E.Drug information journal. 2001, Vol 35, Num 2, pp 539-546, issn 0092-8615Article

A note on therapeutic equivalence and therapeutic ratio with application to studies in respiratory diseasesKÄLLEN, Anders.Drug information journal. 2001, Vol 35, Num 4, pp 1495-1505, issn 0092-8615Article

Analysis of data with imbalance in the baseline outcome variable for randomized clinical trialsWEI, Lynn; JI ZHANG.Drug information journal. 2001, Vol 35, Num 4, pp 1201-1214, issn 0092-8615Article